<DOC>
	<DOCNO>NCT00501514</DOCNO>
	<brief_summary>The purpose study ass whether Growth Hormone ( GH ) improve exercise capacity cardiopulmonary performance patient chronic heart failure .</brief_summary>
	<brief_title>Effects Growth Hormone Exercise Capacity</brief_title>
	<detailed_description>clinical study focus effect GH leave ventricular function hemodynamics . Little known impact GH cardiopulmonary performance exercise capacity . Such data would relevant , give well-recognized importance cardiopulmonary performance exercise capacity marker disease progression predictor mortality patient CHF.Consequently conduct randomise double blind placebo control trial investigate effect three month course GH , adjunctive background therapy , cardiopulmonary performance exercise capacity patient dilate cardiomyopathy CHF.The primary outcome study improvement peak VO2 assess cardiopulmonary exercise testing . Secondary endpoint exercise capacity ejection fraction obtain echocardiography .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Ejection fraction &lt; 40 % Left ventricular internal dimension &gt; 58 mm IIIII NYHA class Stable hemodynamic condition previous three month Sinus rhythm IMA CABG PTCA previous six month Instable angina Major arrhythmia ( Lown class &gt; IV ) Diseases limit exercise capacity Insulin treat diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>chronic heart failure</keyword>
	<keyword>cardiopulmonary exercise</keyword>
	<keyword>oxygen consumption</keyword>
	<keyword>growth hormone</keyword>
</DOC>